Skip to content

Effects of Supervised Breathing Exercise on the Patients with COVID-19 Infection.

Effects of Supervised Breathing Exercise on the Patients with COVID-19 Infection-A Randomized Controlled Trial.

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12621001372875
Acronym
ESBEC
Enrollment
110
Registered
2021-10-11
Start date
2021-11-15
Completion date
2022-07-15
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

With a view to improve breathing difficulty of COVID-19 infected patients this study will be conducted in BSMMU Hospital, Dhaka. A total of 100 patients with COVID-19 will included for the study. Inclusion of the subjects will be confirmed by laboratory findings. Subjects will be selected for the study according to the specific inclusion and exclusion criteria. Informed consent will be taken properly. Patients will be provided breathing exercise along with standard treatment in one group and another one group will be provided standard treatment only. Randomization of the patients into two groups will be done by the way of lottery. Breathing exercise procedure will be given by a trained Physiotherapist under the supervision of a Physiatrist. Exercise will be given daily for four weeks. Follow up will be done weekly for four weeks also. The gathered data will be analyzed statistically. Both paired and unpaired Student’s ‘t’ test and Chi-squired test will be done as applicable. By the present study, the breathing capacity of the patient may be increased and ultimately complication in the lungs may be decreased.

Interventions

Breathing exercises: Breathing exercises will be provided as intervention along with standard treatment, and it will be given by the same Physiotherapist for an individual patient under direct supervision of a Physiatrist. Breathing exercises will be delivered daily for 4 weeks, each session is anticipated to take 12 minutes to complete. And a Bangla written Breathing exercises procedure with pictures of 4 pages document (which is designed for this study only) will be provided to the patients wh

Breathing exercises: Breathing exercises will be provided as intervention along with standard treatment, and it will be given by the same Physiotherapist for an individual patient under direct supervision of a Physiatrist. Breathing exercises will be delivered daily for 4 weeks, each session is anticipated to take 12 minutes to complete. And a Bangla written Breathing exercises procedure with pictures of 4 pages document (which is designed for this study only) will be provided to the patients who will be treated at home & they will be supervised virtually over video calls. Breathing exercises is as follows: 1. Breathing control, 2. Deep breathing exercise, 3. Pursed lip breathing exercise, 4. Training to Controlled cough, 5. Expansion breathing exercise and 6. Blowing exercise. These are the intervention for one group along with standard treatment and other group will be treated with standard treatment only as per WHO guideline.

Sponsors

Bangabandhu Sheikh Mujib Medical University (BSMMU)
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
15 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

• Nasopharyngeal swab samples (tested by RT-PCR) positive for the COVID-19. • Subjects Aged 15 years or more of all genders. • O2 saturation as measured by pulse oximetry (SpO2) greater than 90 % in room air. • Patients having symptoms mild to moderate in nature • A resting respiratory rate 30/m or less than 30/m. • Able to realize the content of questionnaires and who will provide consent.

Exclusion criteria

• Subjects aged more than 70 years of all genders. • Subjects having severe form of COVID-19 • Subjects having severe COPD bronchial asthma and severe ischemic heart disease. .• Chronic liver and kidney disease • Pregnant or lactating women • Patients admitted in ICU

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026